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Lysyl hydroxylase 2 (LH2) catalyzes the hydroxylation of
lysine residues in the telopeptides of fibrillar collagens, which
leads to the formationof stable collagen cross-links. Recentlywe
reported that LH2 enhances the metastatic propensity of lung
cancer by increasing the amount of stable hydroxylysine alde-
hyde-derived collagen cross-links (HLCCs), which generate a
stiffer tumor stroma (Chen, Y., et al. (2015) J. Clin. Invest. 125,
125, 1147–1162). It is generally accepted that LH2modifies pro-
collagen  chains on the endoplasmic reticulum before the
formation of triple helical procollagen molecules. Herein, we
report that LH2 is also secreted and modifies collagen in the
extracellular space. Analyses of lung cancer cell lines demon-
strated that LH2 is present in the cell lysates and the conditioned
media in a dimeric, active form in both compartments. LH2 co-
localized with collagen fibrils in the extracellular space in
human lung cancer specimens and in orthotopic lung tumors
generated by injection of a LH2-expressing human lung cancer
cell line into nude mice. LH2 depletion in MC3T3 osteoblastic
cells impaired the formation of HLCCs, resulting in an increase
in the unmodified lysine aldehyde-derived collagen cross-link
(LCC), and the addition of recombinant LH2 to the media of
LH2-deficient MC3T3 cells was sufficient to rescue HLCC for-
mation in the extracellular matrix. The finding that LH2 modi-
fies collagen in the extracellular space challenges the current
view that LH2 functions solely on the endoplasmic reticulum
and could also have important implications for cancer biology.
Collagens are the main component of the extracellular
matrix and the most abundant protein in mammals (1). Of the
29 types of collagen identified, fibrillar type I collagen is the
most abundant and important in providing tissues and organs
with form andmechanical strength. Type I collagen biosynthe-
sis involves a series of post-translational modifications of nas-
cent procollagen  chains on the endoplasmic reticulum; for
example, specific lysine (Lys) and proline (Pro) residues
undergo hydroxylation, and hydroxylysine (Hyl) residues
undergomono- and di-glycosylation. In the extracellular space,
telopeptidyl Lys and Hyl residues on collagen molecules are
oxidatively deaminated by lysyl oxidases (LOXs),4 producing
the reactive aldehydes Lysald andHylald, respectively, which ini-
tiates a series of condensation reactions to form various cova-
lent intermolecular cross-links involving juxtaposed Lys, Hyl,
and histidine (His) residues on the neighboring molecules,
resulting in the formation ofHylald-derived collagen cross-links
(HLCCs) (2).
HLCCs are generated through a series of intermediate steps
involving multiple enzymatic reactions. For example, HLCCs
are produced through the divalent iminium cross-links
dehydro-hydroxylysinonorleucine (deH-HLNL) when paired
with a juxtaposed Lys residue (i.e.HylaldXLys) on a neighboring
molecule, and deH-dihydroxylysinonorlecine (deH-DHLNL)
with a Hyl residue (i.e. HylaldXHyl). These are then spontane-
ously rearranged to form the stable ketoamines by Amadori
rearrangement then mature into the formation of the trivalent
pyridinium cross-links, pyridinoline (Pyr) (i.e. HylaldXHylald
XHyl) and deoxypyridinoline (d-Pyr) (i.e. HylaldXHylaldXLys).
This pathway is predominant in skeletal tissues such as bone
and cartilage. The Lysald-derived cross-linking pathway, on the
other hand, is predominant in soft connective tissues. Telopep-
tidyl Lysald can condense with another Lysald residue within the
same molecule to form an intramolecular aldol, which then
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eventually leads to a tetravalent intermolecular cross-link, deH-
histidinohydroxymerodesmosine (deH-HHMD) (i.e. Lysald
XLysaldXHisXHyl) (3). In skin and cornea, the Lysald-derived
cross-linking pathway can also lead to a non-reducible, triva-
lent cross-link, histidinohydroxylysinonorleucine by involving
the divalent, iminium cross-link, deH-HLNL (LysaldXHyl), and
a His residue (i.e. LysaldXHylXHis) (4).
Lys hydroxylation is catalyzed by lysyl hydroxylases 1–3
(LH1–3; EC 1.14.11.4) in -X-Lys-Gly- sequences in a reaction
that requires Fe2, 2-oxoglutarate, O2, and ascorbate (5). In
addition to the -X-Lys-Gly- sequence, -X-Lys-Ala-and -X-Lys-
Ser- sequences present in the telopeptides (both N and C ter-
mini) of fibrillar collagens can be hydroxylated. It has been
reported that LH2 catalyzes Lys hydroxylation in the telopep-
tides (6–8) and thereby drives the Hylald-derived collagen
cross-linking pathway (9). Altered LH2 expression has a pro-
found impact on the collagenmatrix (10). Although all LH fam-
ily members (LH1–3) appear to be capable of hydroxylating
helical Lys residues, only LH2 modifies the telopeptidyl Lys
residues (8, 11). Inherited skeletal disorders caused by inacti-
vating mutations in the gene that encodes LH2 and a putative
LH2 foldase, FKBP10 (12–14) demonstrate the importance of
telopeptidyl Lys hydroxylation in normal collagen biosynthesis
and function (15, 16).
It has been reported that LH3, amultifunctional enzyme pos-
sessing both LH and glycosyltransferase activities, can be
secreted and modifies Lys residues on native proteins and pos-
sibly “microfolded” mature collagen molecules in the extracel-
lular space (17). Further studies showed that the glucosyltrans-
ferase activity site is required for LH3 to be secreted into the
extracellular space (18, 19). These findings are the basis of the
current paradigm that LH3 is the only LH isoform with an
extracellular function. However, whether other LH members
are secreted and capable of modifying Lys residues in the extra-
cellular space has not been thoroughly explored.
In breast cancer, lung cancer, sarcoma, and other tumor
types, high LH2 expression increases tumor stiffness, promotes
tumor cell invasion and metastasis, and is a predictor of poor
clinical outcome (20–22). In lung cancer, high LH2 expression
increases the amount of HLCCs in tumor stroma (21). More-
over, LH2 has been detected in the secretome of breast cancer
cells (23), which raises the possibility that LH2 has an extracel-
lular function. In this study we demonstrate that LH2 is associ-
ated with extracellular collagen fibrils in lung cancer tissue
specimens and is secreted into the extracellular space in an
active dimeric form. Importantly, our data strongly indicate
that secreted LH2 is capable of hydroxylating telopeptidyl Lys
residues of collagen in the extracellular space, thereby produc-
ing stable HLCCs. This implies that extracellular LH2modifies
telopeptidyl Lys residues before their LOX-catalyzed conver-
sion to aldehyde, which challenges the current paradigm that
LH2 modifies only intracellular nascent procollagen  chains.
Results and Discussion
LH2 Is Secreted—We initially performed stable isotope label-
ing of amino acids in cell culture on a panel of lung cancer cell
lines (n  52). By mass spectrometric sequencing of proteins,
27 cell lines had detectable LH2 in both cell lysates and condi-
tioned media (Table 1). In the remaining 25 cell lines, LH2 was
detected in only the cell lysates (n  4) or conditioned media
(n 4) or neither fraction (n 17) (Table 1). In contrast, LOX
was detected in 21 cell lines and was almost exclusively in the
conditionedmedia fraction (Table 1). Across the cell line panel,
LH2 levels in the cell lysate and conditioned media were signif-
icantly correlated (Spearman correlation coefficient  0.77,
p  1.31  1011). Stable transfection of H1299 lung cancer
cells, which have low endogenous LH2 levels (Table 1), with a
vector that expresses FLAG-tagged full-length LH2 or an
N-terminally truncated mutant LH2 that lacks the signal pep-
tide showed that the full-length ectopic LH2 was present in
both the cell lysate and conditioned media, whereas the signal
TABLE 1
LH2 and LOX levels in total cell lysate (Cell lysates) and conditioned
media (Media) collected from the indicated cell lines subjected to
SILAC andmass spectrometry
Each value represents the total number of spectral counts within each cellular com-
partment from one biological sample in a single experiment.
Cell
line
LH2 LOX
Cell
lysates Media
Cell
lysates Media
DFC1024 56.82 259.34 0 0
H2030 28.97 130.94 0 0
H1355 16.79 124.78 0 0
H1568 10.77 112.29 0 0
H1993 2.31 94.24 0 0
HCC827 35.96 87.03 0 0
H1651 27.05 70.13 0 0.91
DFC1032 34.27 61.69 0 13.11
H1437 5.28 46.34 0 0
H1563 28.15 38.02 0 0
H820 36.10 36.90 0 0
H2342 0 30.39 0 0
PC9 1.28 18.22 0 12.53
H2228 5.88 17.57 1.60 35.15
HCC2279 9.48 17.28 1.90 35.52
H1395 0 14.70 1.32 54.38
H1373 34.60 12.53 0 13.43
H1792 16.63 11.49 2.02 42.13
H2291 7.15 10.78 0 3.59
HCC4017 4.47 7.73 0 5.16
H1944 30.25 7.46 0 0
H969 1.21 7.23 0 0
H2122 0 6.56 0 0
H650 12.40 6.13 0.77 18.39
H1650 8.71 5.75 0 7.67
H647 1.99 5.15 0 0
H1573 2.53 3.64 0 0
H69AR 8.51 1.95 0 9.76
H69 4.51 1.82 0 1.82
HCC4006 4.59 1.31 0 7.86
HCC1833 0 1.03 0 0
DMS79 0 0 0 1.35
H1299 1.28 0 0 0
H1385 0 0 0 0
H1435 0 0 0 0
H1693 0 0 0 0
H1703 0.48 0 0 0
H1755 0 0 0 0
H1793 0 0 0 9.03
H1838 0 0 0 0
H1975 0 0 0 0
H2009 0 0 0 0
H23 0 0 0 0
H2405 0 0 0 0
H3255 0 0 0 2.79
H522 0 0 0 0
H82 0 0 0 0
H838 1.95 0 0 5.74
H920 0 0 0 0.66
HCC2935 0 0 0 0
HCC4011 4.16 0 1.19 9.10
HCC4019 0 0 0 0
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peptide-deficient LH2 was detected only in the cell lysate (Fig.
1A). On the basis of the lower molecular weight of the signal
peptide-deficient LH2 (Fig. 1A, left panel), we speculated that
aberrant trafficking of the mutant LH2 led to a reduced level of
glycosylation, as there are nine potential glycosylation sites
in humanLH2 (24). Supporting this possibility, treatment of the
total cell lysates with peptide N-glycosidase F decreased the
wild-type LH2 protein to a size similar to that of the mutant
LH2 protein but had no effect on the size of the mutant LH2
protein (Fig. 1B). We then examined human lung cancers to
determine if LH2 is localized in the extracellular space by con-
focal microscopic analysis. In a region of the tumor stroma
containing dense collagen fibers (Fig. 2A), co-staining with
antibodies against LH2 and type I collagen showed that LH2
and collagen indeed co-localized in the extracellular space. In a
different region of the same tumor specimen, spatial overlap-
ping between collagen and LH2 was also confirmed by plotting
intensity of LH2 and collagen staining along a linear region of
the tumor stroma (Fig. 2B). Quantification of LH2 and collagen
I staining within multiple fields of tumor stroma showed that
a fraction of LH2 co-localized with collagen I (Fig. 2C). Fur-
thermore, staining of tumors derived from DFC1024 human
lung cancer cells, which secreted LH2 in culture (Table 1),
with immunogold-labeled anti-LH2 antibodies demon-
strated that most, if not all, of extracellular LH2 was closely
associated with type I collagen fibrils in the extracellular
space (Fig. 3A), and LH2 was also detectable in the cytoplasm
of tumor cells (Fig. 3B). Although we cannot determine if
LH2 binds to collagen directly or indirectly through colla-
gen-binding proteins such as small leucine-rich proteogly-
cans (25), these findings raised the possibility that LH2
directly binds to collagen and modifies telopeptidyl Lys res-
idues in the extracellular space.
Extracellular LH2 Is Functional—LH family members form
homodimers and homodimerization is critical for LH enzy-
matic activity (26). To ascertain the presence of LH2 homodi-
meric complexes in the extracellular space, we utilized a
protein-fragment complementation assay (27) in which the
full-length LH2 protein is fused to the N- or C-terminal frag-
ments of Gaussia luciferase (LH2-G1 and LH2-G2, respec-
tively, Fig. 4A). As an initial validation step, we transfected
the LH2-G1 and LH2-G2 reporters singly or in combination
into 293F cells and measured luciferase activity in cell
lysates. Compared with that achieved with transfection of
either construct alone, co-transfection of the LH2-G1 and
LH2-G2 constructs increased luciferase activity by 200-
fold (Fig. 4B), and reconstitution of luciferase activity was
abrogated by removal of LH2’s putative dimerization motif
(amino acids 562–568) (Fig. 4C). Using this assay, we mea-
sured luciferase activity in conditioned media samples and
cell lysates, which showed the presence of dimeric, active
LH2 in both compartments (Fig. 4, D and E).
To determine whether LH2 canmodify collagen in the extra-
cellular space, we performed a rescue experiment on MC3T3
(MC) cells, which are murine calvaria-derived osteoblasts that
have high LH2 expression and produce amatrix that is enriched
in HLCCs and low in the LCC HHMD (9). After stable trans-
fection of LH2-specific shRNAs to deplete LH2 inMCcells (Fig.
5A), LH2-deficient and scrambled control-transfectedMCcells
were cultured, and cell/matrix layers were collected and sub-
jected to amino acid and cross-link analyses 2 weeks after the
cells had achieved confluence. In all samples analyzed, d-Pyr
levels were at the lower limits of detection and were, therefore,
excluded from the analysis. In contrast to the total collagen
cross-link concentrations, which were only minimally de-
creased by LH2 depletion (Fig. 5B), the LH2-deficient samples
had sharply reduced DHLNL and Pyr (both HLCCs) and
increasedHHMD (LCC) (Fig. 5C), with a corresponding reduc-
tion in theHLCC-to-LCC ratio (5.998 0.4661 versus 0.5094
0.3050) (Fig. 5D). Because HLNL can be derived from either
Lysald or Hylald by pairing with Hyl or Lys, respectively, HLNL
was excluded from the calculation of the HLCC-to-LCC ratio.
However, in the context of the changes in other cross-links, the
moderate increase in HLNL concentrations observed in LH2-
depleted samples was likely due to the decrease in the telopep-
tidyl Hylald levels. To rescue LH2 activity in the extracellular
space of LH2-deficientMC cells, we added 45 nM (final concen-
tration) recombinant LH2 proteins (wild-type or DA inactive
mutant; Fig. 6A) to the media when the cells reached conflu-
ence. Thewild-type recombinant LH2 hydroxylated a synthetic
collagenous substrate, IKGIKGIKG ((IKG)3) (Fig. 6B), indicat-
ing that the protein has enzymatic activity. As a comparison to
the recombinant LH2 protein treatments, LH2-deficient MC
cells were rescued by stable transfection with a vector that
expresses LH2 (wild-type or DA mutant) (Fig. 6C). The matri-
ces were collected and subjected to collagen cross-link anal-
ysis 2 weeks after confluence. Reconstitution with wild-type
LH2 by either approach had no effect on total collagen cross-
FIGURE 1. LH2 underwent glycosylation and was secreted. A, anti-FLAG
Western blotting of total cell lysates or conditioned media isolated from
H1299 cells that hadbeen stably transfectedwith empty vector (Vec) or FLAG-
tagged wild-type (WT) or mutant LH2 lacking the N-terminal signal peptide
(N). Actinwas used as a loading control for the total cell lysates. B, anti-FLAG
Western blotting of lysates fromH1299 cells that had been stably transfected
with FLAG-taggedwild-type (WT) ormutant LH2 lacking theN-terminal signal
peptide (N) after a 5-h incubationof the lysateswith (NFG) orwithout (Mock)
N-glycosidase F. As an additional control,Western blottingwas performedon
lysates that hadnot been subjected to a 5-h incubation (). Actinwas used as
a loading control. Each result is representative of findings from two indepen-
dent experiments.
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link concentrations (Fig. 6D) but significantly increased the
concentration of HLCCs (DHLNL and Pyr) and decreased
LCCs (HHMD) (Fig. 6E), resulting in an increase in the
HLCC-to-LCC ratio (Fig. 6F), whereas reconstitution with
the mutant LH2 did not have this effect (Fig. 6, D–F). Treat-
ment with recombinant LH2 also reversed the reduction in
HLNL levels induced by LH2 depletion (Fig. 6E). These find-
ings show that reconstitution of extracellular LH2 rescued
the LH2-induced collagen cross-link switch, suggesting that
LH2 is capable of hydroxylating collagen in the extracellular
matrix.
The results shown here demonstrate for the first time that
LH2 is secreted andmodifies collagen in the extracellular space.
These findings raisemany important questions, such as theway
in which LH2 secretion is regulated, the sites on which LH2
binds type I collagen, and whether LH2 has extracellular sub-
strates other than collagen telopeptidyl Lys residues. These
findings also have important implications. First, they challenge
the current understanding that LH2 modifies only the nascent
pro- chains before they form a triple helical procollagen mol-
ecule (2, 28) and imply that telopeptidyl Lys residues may
remain accessible to LH2 after procollagen triple helix forma-
tion. Second, because extracellular LH2-catalyzed Lys hydrox-
ylationmust precede LOX-catalyzed conversion of telopeptidyl
Lys to aldehyde, which occurs on the fibril form of collagen but
not on denatured collagen or a collagen monomer (29), our
findings suggest that LH2-induced collagen modifications may
occur in the extracellular space before or at an early stage
of fibrillogenesis, i.e. during procollagen processing and/or
initial fibrillogenesis. Third, because collagen telopeptidyl Lys
hydroxylation impacts the biomechanical properties of colla-
gen cross-links, LH2 secretion may be an important regulatory
step in collagen biosynthesis. Finally, disease states related to
LH2 overproduction such as cancer (20–22, 30) and fibrosis
FIGURE 2. LH2 co-localized with extracellular collagen in a human lung adenocarcinoma. A, fluorescence micrograph of a human lung adenocarcinoma
tissue specimen stained with antibodies against LH2 and collagen I. Nuclei were counterstained with DAPI. Scale bar, 100 m. The inset shows higher
magnification of a region in which LH2 co-localizes with collagen I. LH2 and collagen I signals are pseudocolored in the overlay images. Scale bar, 30m. Two
human lung adenocarcinomas were stained, and the results shown are representative of findings from both tumor specimens. B, to illustrate overlap of LH2
and collagen I in a confocal micrograph of a human lung adenocarcinoma tissue specimen (left), LH2 (green) and collagen I (red) staining intensities were
plottedagainstdistancealongawhite line in the image (left).C, the fractionof LH2 that co-localizeswith collagen Iwithin single fields (circles) of twohuman lung
adenocarcinomas as determined by Pearson’s correlation coefficient.
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(31, 32) may be effectively treated with anti-LH2 neutralizing
antibodies that can inhibit extracellular LH2.
Experimental Procedures
Plasmids—To create the pLVX-Puro2 plasmid, we modified
the pLVX-Puro plasmid (Clontech, Mountain View, CA) by
adding the SbfI and NotI cutting sites after the XbaI site. The
C-terminal 3 FLAG-tagged WT LH2 cDNAs were cloned
into the XbaI and NotI sites on pLVX-Puro2 to generate the
LH2–3FLAG-WT expression plasmid. The LH2–3FLAG
cDNA without the signal peptide was amplified by PCR and
cloned into the XbaI andNotI sites on pLVX-Puro2 to generate
the LH2–3FLAG-N expression plasmid. The N terminus
(G1, amino acids 193) or the C terminus (G2, amino acids
94169) of Gaussia luciferase were fused to the WT LH2 C
terminus with the polypeptide linker (Gly-Gly-Gly-Gly-Ser)2
and cloned into the XbaI and NotI sites on pLVX-Puro2 to
generate the LH2-G1 and LH2-G2 expression plasmids. The
dimerizationmotif (amino acids 562568) on LH2was deleted
by overlapping PCR to generate the LH2-DD-G1 and LH2-
DD-G2 expression plasmids. The pLKO.1_scramble and
pLKO.1_LH2-SH5 plasmids were constructed as de-
scribed previously (21). To create the pEF-bsr plasmid for the
rescue experiment, we modified the pLVX-Puro plasmid by
replacing the CMV promoter with the EF1 promoter,
replacing the puromycin-resistant gene with the blasticidin-
resistant gene, and adding the SbfI and NotI cutting sites
after the XbaI site. The WT LH2 cDNA was released from
the pLVX-Puro2-LH2–3FLAG and subcloned into the XbaI
and NotI sites on the pEF-bsr plasmid. The D689A mutant
was generated by site-directed mutagenesis using overlap-
ping PCR.
Cell Culture—All cells were obtained fromATCC and grown
in a humidified atmosphere with 5% CO2 at 37 °C. LH2-defi-
cient MC3T3-E1 (MC) cells were cultured in minimum essen-
tial medium  supplemented with 10% FBS. 293T and 293F
were cultured in a 1:1 mixture of DMEM and Ham’s F-12
medium supplemented with 10% FBS. Human lung cancer cells
were grown in RPMI 1640 with 10% FBS and 1% penicillin/
streptomycin. Stable isotope labeling by amino acids in cell cul-
ture (SILAC) was done as described previously (33). Briefly,
cells were grown for seven passages in RPMI 1640 supple-
mented with [13C]lysine and 10% dialyzed FBS according to the
standard SILAC protocol (34).
Proteomic Analysis of Human Lung Cancer Cells—For pro-
tein fractionation, we used a Shimadzu HPLC system equipped
with 2 LC-20AD pumps, 1 dual-wavelength SPD-20A UV
detector (220 nm and 280 nm), 1 FRC-10A fraction collector, 1
CTO-20A column oven, and 1 SCL-10 controller. The whole
system was controlled with an EZ Start work station (version
7.4 SP3). Protein samples from the total cell extract or the frac-
tion secreted in media were reduced and alkylated with acryl-
amide, loaded onto an RPGS reversed-phase column (4.6 mm
FIGURE 3. LH2 co-localized with extracellular collagen in tumors generated by subcutaneous injection of DFC1024 lung cancer cells into nudemice.
Representative electron microscopic images of a DFC1024 tumor tissue section stained with gold particle-labeled IgG or anti-LH2 antibodies. Gold particles
that localize on extracellular collagen fibers (A) and in the cytoplasmof tumor cells (B) are indicated (arrows).Dashes indicate location of nuclearmembrane (B).
Scale bar, 200 nm. The results shown are representative of a single tumor generated in 1 mouse.
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(inner diameter) 150 mm, 15 m, 1000 Å, Column Technol-
ogy Inc., Fremont, CA), and subjected to desalting with 95%
mobile-phase A (0.1% TFA in 95% H2O) at a flow rate of 3
ml/min for 5 min. Proteins were eluted from the column at a
flow rate of 2.1 ml/min with gradient elution that included
an increase from 5% to 70%mobile phase B (0.1% TFA in 95%
acetonitrile) over 25 min, 70% to 95% mobile phase B for 3
min, a wash step to hold at 95%mobile phase B for 2 min, and
a re-equilibration step at 95% mobile phase A for 5 min.
Fractions were collected in 1.1-ml microtubes (Dot Scien-
tific Inc., Burton, MI) at 20-s intervals and stored at 80 °C
until use.
The lyophilized protein samples were dissolved in 100 mM
NH4HCO3 (pH8.5) followed by overnight in-solution digestion
with trypsin at 37 °C. before LC-MS/MS analysis, the digestion
was quenched by adding 5 l of 1.0% formic acid solution.
Briefly, peptides were separated by reversed-phase chromatog-
raphy using a nano-HPLC system (Eksigent, Dublin, CA) cou-
pled onlinewith an LTQ-Orbitrapmass spectrometer (Thermo
Fisher Scientific, Inc., Waltham, MA). Mass spectrometer
parameters were as follows: spray voltage, 2.5 kV; capillary tem-
perature, 200 °C; FT resolution, 100,000; FT target value, 8 
105; LTQ target value, 1  104; 1 FT microscan with 850-ms
injection time; 1 LTQ microscan with 100-ms injection time.
Mass spectra were acquired in a data-dependent mode with
the m/z range of 400–2000. The full mass spectrum (MS
scan) was acquired by the FT, and the tandemmass spectrum
(MS/MS scan) was acquired by the LTQ with 35% normal-
ized collision energy. The acquisition of each full mass spec-
trum was followed by the acquisition of MS/MS spectra for
the 5 most intense2 or3 ions within a 1-s duty cycle. The
minimum signal threshold (counts) for triggering anMS/MS
scan for a precursor occurring during an MS scan was set at
1000.
FIGURE 4. LH2 formed homodimers in the extracellular space. A, schema of reporters containing full-length LH2 fused to the N-terminal (G1) or C-terminal
(G2) domains of Gaussia luciferase (hGluc). LH2, G1, and G2 are color-coded (the legend). B, luciferase activities weremeasured in total cell lysates of 293F cells
transiently transfected with the indicated reporters or empty vector (Vec). Data are the means  S.D.) of triplicate samples. C, luciferase activities were
measured in total cell lysates of 293F cells transfectedwith the indicated reporters or empty vector (Vec). Full-length LH2 (WT). Mutant LH2 lacking the putative
dimerizationmotif (DD). Data are themeans S.D. of triplicate samples. D, luciferase activities weremeasured in total cell lysates (Cell lysates) or conditioned
media (Media) isolated from 293F cells transiently transfected with the indicated reporters or empty vector (Vec). Data are the means  S.D. of triplicate
samples. E, luciferase activities were measured in total cell lysates (Cell lysates) or conditionedmedia (Media) isolated from H1299 cells transiently transfected
with the indicated reporters or empty vector (Vec). Data are the means S.D. of triplicate samples. The results shown are representative of two independent
experiments.
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The acquired LC-MS/MS data were processed by the
Computational Proteomics Analysis System (18). Briefly, LC-
MS/MS data were first converted to mzXML format using
ReAdW software (version 1.2) to generate the peak list for pro-
tein database searching. The X!Tandem search engine (version
2005.12.01) parameters included cysteine alkylated with acryl-
amide (71.0371@C) as a fixed modification and methionine
oxidation (15.99491@M) as a variable modification. Data were
searched against the International Protein Index human pro-
tein knowledgebase (version 3.57), which contains entries for
76,542 proteins. The minimum criterion for peptide matching
was a Peptide Prophet Score of 0.2. Peptides meeting this
criterion were grouped to protein sequences using the Protein
Prophet algorithm at an error rate of 5%. The total peptide
count in each fractionwas used as ameasure of protein concen-
tration within that fraction.
The proteomic search results from lung cancer cell lines was
obtained and combined in a MySQL database application. The
total number of spectral counts for each protein group within
each sample from the total cell extract and the secreted media
compartment was normalized to total spectral count set at
50,000 using R (v3.0.1)/RStudio (v0.97.551; RStudio, Inc). The
data were further used for differential protein analysis between
cell lines.
Generation of Stable Cell Lines—Parental MC cells were
infected with lentiviruses carrying LH2-SH5 shRNA or the
scramble control that had been packaged in 293T cells using
the pMD2.G and psPAX2 plasmids. After 48 h, the cells were
selected with puromycin (10 g/ml) for 2 weeks to generate
LH2-deficient MC cells (MC_LH2-SH5 cells). To restore LH2
expression, the MC_LH2-SH5 cells were infected with lentivi-
ruses carrying the cDNA of WT LH2 or inactive LH2 (D689A)
and selected with blasticidin (10 g/ml) for 2 weeks.
Protein Complementation Assay—Plasmids with the LH2
andGaussia luciferase fusions were co-transfected at a 1:1 ratio
into 293F or H1299 cells plated on 24-well plates using the
FuGENE 6 transfection reagent (Promega,Madison,WI). After
48 h, the cells were washed with PBS, 400 l of passive lysis
buffer (Promega) was added to each well, and the plate was
shaken for 15 min at room temperature. Then, 100 l of the
lysate was mixed with 100 l of native coelenterazine (Nanoli-
ght Technology) stock solution.Native coelenterazinewas used
at a final concentration of 20 M. The signal intensities of
the reaction were read using a Synergy 2 microplate reader
(BioTek, Winooski, VT).
Quantitative Real-time PCR—Quantitative real-time PCR
(Q-PCR) was done as described previously (21). Briefly, total
RNAwas isolated from the cells usingTRIzolQ-PCRassays and
reverse-transcribed into cDNA with qScript cDNA SuperMix
(Quanta BioSciences, Gaithersburg,MD). ThemRNA level was
analyzed using a SYBR Green-based system (Applied Biosys-
tems, Waltham, MA). mRNA levels were normalized on the
basis of mRNA for ribosomal protein L32 (Rpl32). The primers
for Q-PCR of Lh2 and Rpl32 have been described previously
(21).
Western Blotting—Western blotting was performed as
described previously (21). Briefly, cells were washed with PBS
and lysedwith cell lysis buffer (Cell Signaling Technology, Dan-
vers, MA) to extract total proteins. Cell lysates were separated
by SDS-PAGE, transferred onto nitrocellulose transfer mem-
brane (GE Healthcare), and then incubated with primary
antibodies and horseradish peroxidase-conjugated second-
ary antibodies (GE Healthcare). Protein bands were visual-
ized with Pierce ECL Western blotting substrate (Thermo
Fisher Scientific).
Purification of Recombinant LH2 Protein—Human LH2b
recombinant proteins (residues 33–758, WT and inactive
D689A mutant) were produced from FreeStyle CHO-S cells
(Invitrogen) via large-scale transient transfection with polyeth-
yleneimine as described previously (35, 36). The recombinant
LH2b proteins were then purified from CHO-S cell-condi-
tioned media utilizing immobilized metal affinity chromatog-
raphy and gel filtration chromatography.
FIGURE 5. LH2 depletion decreased HLCCs and increased LCCs. A, the bar graph illustrates the results of Q-PCR analysis of LH2mRNA levels in MC cells
stably transfectedwith vectors expressing LH2 shRNA (SH5) or scrambled control shRNA (SCR). The results are expressed as themeans S.D. of triplicate
samples. The mRNA levels of the indicated transfectants are relative to those of the control transfectants, which were set at 100%. The blots on the right
show the results of Western blot analysis of the MC transfectants. Actin was used as the loading control. The results shown are representative of two
independent experiments. B–D, quantification of total collagen cross-links (B), HLCCs, LCCs, and HLNL (C) and the ratio of HLCCs-to-LCCs (D) in the MC
transfectants. Total collagen cross-links was the sum of HLCCs (DHLNLPyr)  LCCs (HHMD)  HLNL. The HLCC-to-LCC ratio was calculated as
(DHLNLPyr)/HHMD. Data are the means  S.D. of triplicate biological samples in a single experiment. p values, 2-tailed Student’s t test.
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LH2 Activity Assay—An LH2 activity assay was performed in
reaction buffer (20mMHEPES buffer (pH 7.4), 150mMNaCl) at
37 °C for 1 h with 1 M LH2 enzyme, 50 M FeSO4, 100 M
-ketoglutarate, 500 M ascorbate, 1 mM peptide substrate
((IKG)3), and 1.5 M catalase as described previously (37). Pep-
tide substrate hydroxylation was measured directly by amino
acid analysis (see below).
Recombinant LH2 Protein Treatment—MC_LH2-SH5 cells
were cultured in 20-cm culture plates, and the treatment
started when the cells reached confluence. Recombinant
LH2-WTandLH2-DAproteinwere added every other daywith
fresh medium supplemented with 100 g/ml ascorbic acid
(Sigma). The final concentration for the recombinant protein
was 45 nM. The cells were treated for 2 weeks, and then cell
matrixes were collected for the collagen cross-linking analysis.
Amino Acid Analysis—The peptide substrates with or with-
out LH2 treatment were hydrolyzedwith 6 NHCl and subjected
to amino acid analysis as described (38). The % of Lys hydrox-
ylation was calculated by Hyl/(LysHyl). Amino acid analysis
of the reduced collagen from cell/matrix layer was also per-
formed in the same manner to determine the amount of Hyp
(22).
Immunofluorescent Staining and Colocalization Analysis—
Immunofluorescent staining of human lung cancer tissue sec-
tions was performed as described elsewhere (39). The LH2
antibody (R&D systems, catalog #MAB4445) was used in our
previous study and showed high specificity (21). Anti-type I
collagen antibody (ab34710) (Abcam) that recognizes native
type I collagenmolecule was used to stain type I collagen fibrils
in the extracellular space. For widefield fluorescence micros-
copy, images were acquired with a 20 (0.75 NA) objective on
a Nikon Eclipse Ti inverted widefield microscope equipped
with DS-Qi2 monochrome sCMOS camera (for fluorescence)
and DS-Ri2 color sCMOS camera (for color brightfield) using
FIGURE 6. Extracellular LH2 was sufficient to rescue the collagen cross-link switch. A, SDS-PAGE of immobilized metal affinity chromatography/gel
filtration-purified wild-type LH2 (WT) or enzymatically-inactive D689A mutant LH2 (DA) under reducing (R) and non-reducing (NR) conditions. The
positions of the molecular weight markers (MW) are indicated. The results shown are representative of two independent experiments. B, Hyl levels by
amino acid analysis of (IKG)3 reacted with wild-type LH2. Control reactions were performed in the absence of (IKG)3 (LH2) or LH2 ((IKG)3). Each result is
from one sample in a single experiment. C, Western blot analysis of MC_LH2-SH5 cells transfectedwith control vector (Vec) or vectors expressingWT LH2
or inactive LH2 (DA) to reconstitute intracellular and extracellular LH2. Actin was used as the loading control. The results shown are representative of two
independent experiments. D–F, quantification of total collagen cross-links (D), HLCCs, LCCs, and HLNL (E), and the ratio of HLCCs-to-LCCs (F). Total
collagen cross-links was the sum of HLCCs (DHLNLPyr) LCC (HHMD)HLNL. For each assay, the bars on the left are from cells treated with or without
(Con) recombinant LH2 protein (treatment), and the bars on the right are from cells stably transfected with empty (Vec) or LH2 expression vectors
(transfection). The HLCC-to-LCC ratio was calculated as (DHLNLPyr)/HHMD. The data are themeans S.D. from triplicate biological samples in a single
experiment. p values, 2-tailed Student’s t test.
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NIS Elements software (Nikon). For quantitative colocalization
analysis, confocal images were acquired with Nyquist sampling
criteria using a 40 (0.95 NA) objective on a Nikon A1 con-
focal microscope using NIS Elements software. Raw images
were iteratively deconvolved with CMLE algorithm inHuygens
Professional version 15.05 (Scientific Volume Imaging, The
Netherlands). Colocalizationwas estimatedwith colocalization
analyzer plugin in Huygens Pro. Intensity plots of signal inten-
sity (y axis) against distance in microns (x axis) were generated
from 8-bit thresholded images with RGB profile plot in ImageJ
(National Institutes of Health, Bethesda, MD).
Immunogold Labeling and Transmission Electron Micro-
scopy—Two million DFC1024 human lung cancer cells were
injected subcutaneously into nude mice to generate tumors.
Tumors were fixed for 2 h at room temperature in phosphate-
buffered saline (PBS) containing 2% paraformaldehyde. Fixed
tissues were washed in PBS and then blocked overnight in PBS
containing 1% bovine serum albumin and 0.1% Triton X-100 at
4 °C. This was followed by overnight incubation in blocking
buffer containing anti-LH2 antibody (10 g/ml) or control
non-immune isotyped matched IgG2b antibody (10 g/ml).
After incubation with the primary antibody, the samples were
washed in PBS and incubated overnight in NanogoldTM-anti-
mouse secondary antibody (Nanoprobes, catalog #2002, 1.4 nm
Nanogold particle) diluted 1:40 in blocking buffer. After a PBS
wash, the sampleswere incubated inGoldEnhance EMTM toner
(Nanoprobes, catalog #2113) for 7 min and then washed in
deionized water before fixing in 0.1 M sodium cacodylate buffer
containing 2.5% glutaraldehyde for 60 min. The samples were
then post-fixed in 1% osmium, dehydrated through an acetone
series, infiltrated, and embedded in Embed-812 (Electron
Microscopy Sciences, Hatfield, PA), sectioned (80–100 nm),
and stained with lead and uranyl acetate. Sections were viewed
on an FEI Tecnai 12 transmission electron microscope operat-
ing at 80 keV.
Collagen Cross-link Analysis—For the collagen cross-link
analysis, MC_LH2-SH5 cells treated or non-treated with
recombinant LH2 or inactive LH2 (n 3/group) were cultured
for 2 weeks as described (9, 40). The cell/matrix layer was first
washed with cold PBS, scraped, and collected by centrifugation
at 10,000 rpm for 30 min. The pellets were pulverized in liquid
nitrogen using a Spex Freezer Mill (Spex, Metuchen, NJ),
washed with cold PBS and cold distilled water, lyophilized, and
weighed. Aliquots were reduced with standardized NaB3H4
and hydrolyzed with 6 N HCl. The hydrolysates were then
subjected to amino acid and cross-linking analyses as
described previously (38). Upon reduction, the reducible
cross-links, i.e. deH-DHLNL/ketoamine (Hylald X Hyl), deH-
HLNL/ketoamine (Hylald X Lys or Lysald X Hyl), and deH-
HHMD (Lysald X Lysald X His X Hyl) are reduced to DHLNL,
HLNL, and HHMD, respectively. Hereafter, the terms
DHLNL, HLNL, and HHMD will be used for both the unre-
duced and reduced forms. These reducible cross-links were
identified and measured as their reduced forms. The mature
trivalent cross-links, Pyr and d-Pyr, were simultaneously
analyzed by their fluorescence. All cross-links were quanti-
fied as the mol/mol collagen based on the value of 300 resi-
dues of Hyp per collagen molecule.
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